Clinical Trial Update: Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority multicenter trial comparing two weight-based doses of botulinum toxin injected into the detrusor for pediatric neurogenic detrusor overa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Neurogenic Bladder

Drugs mentioned

• Botulinum toxin detrusor injection (botulinum toxin type A)

Snippet

Sponsor: CHU de Reims | Conditions: Neurogenic Vesical Hyperactivity Syndrom | Phase 3 | Status: COMPLETED